https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-09-01 / J. Neurosurg. 2019 09;131(3):657-666
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-09-01 / J. Neurosurg. 2019 09;131(3):657-6662019-09-01 00:00:002019-09-01 00:00:00The current state of immunotherapy for gliomas: an eye toward the future
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-08-30 / Biomedicines 2019 Aug;7(3)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-08-30 / Biomedicines 2019 Aug;7(3)2019-08-30 00:00:002021-11-15 13:22:59Breaking Therapy Resistance: An Update on Oncolytic Newcastle Disease Virus for Improvements of Cancer Therapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-08-26 / World J Clin Cases 2019 Aug;7(16):2143-2154
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-08-26 / World J Clin Cases 2019 Aug;7(16):2143-21542019-08-26 00:00:002020-08-26 14:20:49Application of Newcastle disease virus in the treatment of colorectal cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-05-31 / J Clin Oncol 37, 2019 (suppl; abstr e14212)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-05-31 / J Clin Oncol 37, 2019 (suppl; abstr e14212)2019-05-31 00:00:002019-05-31 00:00:00Possible viral oncolysis by members of the Reoviridae and Paramyxoviridae families (an in vitro study).
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-05-29 / Front Oncol 2019;9:436
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-05-29 / Front Oncol 2019;9:4362019-05-29 00:00:002022-09-29 14:03:17STAT3 Contributes To Oncolytic Newcastle Disease Virus-Induced Immunogenic Cell Death in Melanoma Cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-04-29 / Int. J. Cancer 2019 10;145(7):1958-1969
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-04-29 / Int. J. Cancer 2019 10;145(7):1958-19692019-04-29 00:00:002020-08-26 14:13:53Oncolytic virotherapy enhances the efficacy of a cancer vaccine by modulating the tumor microenvironment
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-04-23 / Saudi J Biol Sci 2020 Jan;27(1):47-52
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-04-23 / Saudi J Biol Sci 2020 Jan;27(1):47-522019-04-23 00:00:002020-08-26 14:21:10Oncolytic Newcastle disease virus reduces growth of cervical cancer cell by inducing apoptosis
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-04-04 / BMC Cancer 2019 Apr;19(1):315
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-04-04 / BMC Cancer 2019 Apr;19(1):3152019-04-04 00:00:002020-12-14 17:17:19Regression of solid breast tumours in mice by Newcastle disease virus is associated with production of apoptosis related-cytokines
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-03-05 / Cancers (Basel) 2019 Mar;11(3)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-03-05 / Cancers (Basel) 2019 Mar;11(3)2019-03-05 00:00:002019-03-05 00:00:00Recent Advances in Cancer Stem Cell-Targeted Immunotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-01-01 / Crit Rev Immunol 2019;39(3):211-221
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-01-01 / Crit Rev Immunol 2019;39(3):211-2212019-01-01 00:00:002019-01-01 00:00:00Immunotherapy for Triple-Negative Breast Cancer: Latest Research and Clinical Prospects
